Evaluation of the effect of topical clindamycin in prevention of alveolar osteitis

Investigation the effectiveness of using topical clindamycin nanoparticles gel in the prevention of alveolar osteitis

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2017021214333N67

Enrollment

300

Registered

2017-04-08

Start date

2017-02-28

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry socket. Alveolitis of jaws

Interventions

Intervention 1: in the Intervention group treatment with clindamycin gel tube will be done. Intervention 2: In the control group routine treatment includes treatment with gel tube without antibiotics

Treatment - Drugs

in the Intervention group treatment with clindamycin gel tube will be done

In the control group routine treatment includes treatment with gel tube without antibiotics will be done

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients needing tooth extractions; Age between 18 and 64 Exclusion criteria: Hypersensitivity to clindamycin; Antibiotic therapy within the past three months.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Alveolar osteitis incidence. Timepoint: Baseline, third and seventh days after tooth extraction. Method of measurement: Based on the observation by doctor.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSaeed Niazi

Kermanshah University of Medical Sciences

niazi_saeed_1992@yahoo.com+98 83 3721 8209

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026